Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Ulinastatin on the Action of Nondepolarising Muscle Relaxants Rocuronium / Cisatracurium
NCT05716256Completed
- Sponsor
- Huazhong University of Science and Technology
- Start
- Feb 2023
- Primary completion
- Jun 2023
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Randomised trial of ulinastatin (4 arms), sponsored by Huazhong University of Science and Technology. Primary endpoint: Clinical Duration 25%. Started Feb 2023; status: completed.
02
Drugs
ulinastatin
Beyond the preview
Go deeper on NCT05716256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05716256.